Approval · Notice of Compliance 2593 · 2001
ZERIT: Notice of Compliance 2593
Issued January 25, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2593
- Date
- January 25, 2001
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication: for use in combination with other antiretroviral agents in the treatment of hiv-1 infection
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZERIT | Not yet assigned | — |